Bromodomain and extra-terminal domain (BET) proteins regulate melanocyte differentiation

BACKGROUND: Pharmacologic inhibition of bromodomain and extra-terminal (BET) proteins is currently being explored as a new therapeutic approach in cancer. Some studies have also implicated BET proteins as regulators of cell identity and differentiation through their interactions with lineage-specifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Trivedi, Archit, Mehrotra, Aanchal, Baum, Caitlin E., Lewis, Brandon, Basuroy, Tupa, Blomquist, Thomas, Trumbly, Robert, Filipp, Fabian V., Setaluri, Vijayasaradhi, de la Serna, Ivana L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063807/
https://www.ncbi.nlm.nih.gov/pubmed/32151278
http://dx.doi.org/10.1186/s13072-020-00333-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063807/
https://www.ncbi.nlm.nih.gov/pubmed/32151278
http://dx.doi.org/10.1186/s13072-020-00333-z

Ejemplares similares